The results of the clinical study were reinforced by the DGE analyses, which revealed decreased myostatin expression in denervated gastrocnemius muscle in mice, skeletal muscle of SMA transgenic mice, and iliopsoas muscle (severely affected muscle) of SMA patients with advanced disease. The gene discussed is MSTN; the disease is proximal spinal muscular atrophy.